Israel’s agritech sector is experiencing very positive momentum, with three major shows of confidence in the past week: the sale of Algatechnologies to GrovePoint Capital for an estimated value of $50 Million, the sale of engineered seeds company Rosetta Green to Monsanto for $35 Million, and the announcement of
A battle is quietly being waged between the industry that produces genetically modified seeds and scientists trying to investigate the environmental impacts of engineered crops. Although companies such as Monsanto have recently given ground, researchers say these firms are still loath to allow independent analyses of their patented — and profitable — seeds.
In February 2009, frustrated by industry restrictions on independent research into genetically modified crops, two dozen scientists representing public research institutions in 17 corn-producing states told the U.S. Environmental Protection Agency (EPA) that the companies producing genetically modified (GM) seed “inhibit public scientists from pursuing their mandated role on behalf of the public good” and warned that industry influence had made independent analyses of transgenic crops impossible.
Unprepared for the scientists’ public protest and the press accounts that followed it, the industry, through its American Seed Trade Association (ASTA), met with crop scientists. Late last year, ASTA agreed that, while still restricting research on engineered plant genes, it would allow researchers greater freedom to study the effects of GM food crops on soil, pests, and pesticide use, and to compare their yields and analyze their effects on the environment.
While many scientists expressed optimism about the agreement, questions remain over whether — and how soon — it will alter what has been a research environment rife with obstructions and suspicion.